EVALUATING THE USE OF DROTRECOGIN ALFA (ACTIVATED) IN THE TREATMENT OF SEVERE SEPSIS IN FRANCE: OVERVIEW OF A 3-YEAR SURVEY PERIOD

被引：0
|
作者：
Cariou, A. [1 ]
Montravers, P. [2 ]
Guidet, B. [3 ]
Martin, C. D. [4 ]
Fillon, F. [5 ]
Granados, D.
Sapin, H. [5 ]
Tcherny-Lessenot, S. [5 ]
Payen, D. [6 ]
机构：
[1] Cochin Hosp, Med Intens Care Unit, Paris, France
[2] Hop Xavier Bichat, Surg Intens Care Unit, Paris, France
[3] St Antoine Hosp, Med Intens Care Unit, Paris, France
[4] North Hosp, Med Intens Care Unit, Marseille, France
[5] Eli Lilly & Co, Dept Med, Suresnes, France
[6] Univ Paris 07, Lariboisiere Univ Hosp, Med Intens Care Unit, Paris, France
来源：
INTENSIVE CARE MEDICINE | 2010年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
0425
引用
收藏
页码：S192 / S192
页数：1
相关论文
共 50 条
  • [1] Drotrecogin alfa (activated): the treatment for severe sepsis?
    Vincent, Jean-Louis
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (11) : 1763 - 1777
  • [2] Drotrecogin Alfa (Activated) in the Treatment of Severe Sepsis
    Vincent, Jean-Louis
    [J]. CURRENT DRUG SAFETY, 2007, 2 (03) : 227 - 231
  • [3] The development of drotrecogin alfa (activated) for the treatment of severe sepsis
    Macias, WL
    Yan, SB
    Grinnell, BW
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2004, 27 (05): : 360 - 370
  • [4] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Choi, Goda
    de Pont, Anne-Cornelie J. M.
    Schultz, Marcus J.
    [J]. CRITICAL CARE, 2006, 10 (04):
  • [5] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Goda Choi
    Anne-Cornélie JM de Pont
    Marcus J Schultz
    [J]. Critical Care, 10
  • [6] Use of drotrecogin alfa (activated) in older patients with severe sepsis
    Alexander, SL
    Ernst, FR
    [J]. PHARMACOTHERAPY, 2006, 26 (04): : 533 - 538
  • [7] Drotrecogin alfa (Activated) for the treatment of severe sepsis and septic shock
    Rice, TW
    Bernard, GR
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2004, 328 (04): : 205 - 214
  • [8] Drotrecogin alfa (activated) treatment of older patients with severe sepsis
    Ely, EW
    Angus, DC
    Williams, MD
    Bates, B
    Qualy, R
    Bernard, GR
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) : 187 - 195
  • [9] Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer
    Russo, G.
    La Spina, M.
    Disma, N.
    Astuto, M.
    [J]. BONE MARROW TRANSPLANTATION, 2006, 38 (08) : 575 - 576
  • [10] The efficacy of drotrecogin alfa (activated) for the treatment of pediatric severe sepsis
    Giroir, B
    Goldstein, B
    Nadel, S
    Wang, DZ
    Levy, H
    Williams, M
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A152 - A152
12345